Therefore, our findings are more in line with those of a recent meta-analysis showing increased DSP prevalence in subjects with type 2 diabetes with NAFLD, but not in those with type 1 diabetes [25]. This evidence concerns the gene DSP and metabolic dysfunction-associated steatotic liver disease.